GASTROESOPHAGEAL CANCER (GC)
Clinical trials for GASTROESOPHAGEAL CANCER (GC) explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER (GC) trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER (GC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug begins human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first human study of an experimental drug called CTX-10726 for patients with advanced cancers that have stopped responding to standard treatments. The trial will test increasing doses of the drug to find the safest amount and see how the body processes it. Researchers…
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 02:20 UTC
-
New drug combo targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC